INSIGHTS ON CLINICAL TRIAL DESIGN
-
![IRT Getty 1407865352]( "Unique IRT Implementation Considerations For Personalized Medicine Trials")
Unique IRT Implementation Considerations For Personalized Medicine TrialsThe rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.
-
![GettyImages-1489414892 Technological Software Engineering Department Manager Using A Laptop]( "The Future Of Patient Participation In Clinical Research")
The Future Of Patient Participation In Clinical ResearchTo address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.
-
![GettyImages-1131359216-doctor-blood-pressure-exam]( "Navigating Tension Of Clinical Equipoise In Precision Oncology Trials")
Navigating Tension Of Clinical Equipoise In Precision Oncology TrialsThis roundtable discussion examines the tension between legacy methods and modern innovation, exploring the complexities of hybrid trial designs and the changing regulatory landscape.
-
![Regulatory network digital EHR EMR patient data GettyImages-1298626492]( "Disclosure Management System: Build Or Buy?")
Disclosure Management System: Build Or Buy?Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.
-
Advancing Alzheimer's Disease Therapies9/3/2025
By uniting scientific innovation with patient-focused execution, the next generation of alzheimer’s disease (AD) therapies has the potential to deliver a transformative impact on global health.
-
The Final DCT Guidance: I'm Not Mad At It12/13/2024
Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
Pharma R&D Annual Review Supplement: New Active Substances4/15/2026
Last year was by some distance the best year ever in terms of new active substances. Its total of 105 new debuts easily outstrips that of the previous record holder 2021’s 97. In 2025 we saw 97 new drugs, compared to the previous record of 84.
-
Keeping Oncology Programs Moving As Complexity Increases5/1/2026
As oncology trials grow more complex, speed depends on clarity. Consistent oversight and shared data help teams make confident decisions faster without losing control.
-
Expanding Clinical Research In East Africa With Digital Innovation12/11/2025
Africa carries 25% of the world’s disease burden but hosts only 1% of clinical trials. Discover technology-driven strategies that close this gap and transform research access in underserved regions.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![board meeting]( "IRB Review Services For Phase I Research")
With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.
-
![patient and doctor iStock-1211396399]( "Special And Patient Populations")
Altasciences has the advanced level of clinical expertise required to successfully recruit and conduct clinical trials involving special and patient populations.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "How Trial Compass Is Solving Psychiatric Trial Enrollment")
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
-
![GettyImages-1403159350 patient experience]( "Educate, Engage, Enroll: Accelerating Patient Recruitment")
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
-
![Patient- doctor- GettyImages-2155775525]( "Therapeutic Experience: Supporting Recruitment And Retention")
CSS offers customized patient recruitment and retention solutions across the globe, ensuring successful enrollment for clinical trials across various therapeutic areas.
